United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 5,072 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132,836 | 134,358 |
| Total Cites | 14,738 | 16,987 |
| H-index | 57 | 65 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 539 | 653 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 7,081 | 8,167 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,152 | 11,961 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.42 |
| Self-Citation Percentage |
13.24%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,750 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,230 | 125,685 |
| Total Cites | 13,818 | 15,895 |
| H-index | 56 | 62 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 529 | 641 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 6,742 | 7,768 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,400 | 11,135 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.43 |
| Self-Citation Percentage |
13.07%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,605 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118,060 | 121,578 |
| Total Cites | 13,308 | 15,259 |
| H-index | 56 | 61 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 516 | 620 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 6,541 | 7,500 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,000 | 10,711 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.42 |
| Self-Citation Percentage |
12.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,506 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110,928 | 115,481 |
| Total Cites | 12,243 | 14,030 |
| H-index | 54 | 59 |
| Hm-index | 20 | 20 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 501 | 604 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 6,135 | 7,031 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,171 | 9,799 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.43 |
| Self-Citation Percentage |
12.74%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.